Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02531360 · ClinicalTrials.gov registry record · Early Phase 1
Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies
A Early Phase 1 study, sponsored by Molecular NeuroImaging.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 7
- Enrollment target
NCT02531360: Completed Early Phase 1 study, sponsored by Molecular NeuroImaging.
NCT02531360 is a Early Phase 1 study that has completed, run by Molecular NeuroImaging. The registered enrollment target is 7 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02531360, a Early Phase 1 study, has completed, sponsored by Molecular NeuroImaging.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
The overall goal of this imaging trial is to characterize \[18F\]MNI-815, a PET radioligand for imaging Tau.
Primary Outcome
The PET imaging outcome measure to evaluate tau burden will be the standardized uptake value (SUV), which will be calculated for the areas of interest by using the established methods for normalizing to subject weight and injected dose.
Interventions
- DRUG [18F]MNI-815 (MNI-815)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2015-05 |
| Est. Completion | 2016-08 |
| Phase | Early Phase 1 |
What the finished NCT02531360 record still lists
NCT02531360 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 1 intervention - of which [18F]MNI-815 (MNI-815) is the first listed.
NCT02531360 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02531360 about?
NCT02531360 is a clinical study titled "Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies". The overall goal of this imaging trial is to characterize \[18F\]MNI-815, a PET radioligand for imaging Tau.
What is the current status of trial NCT02531360?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 7 participants. The study started on 2015-05. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02531360?
The interventions under investigation include: [18F]MNI-815 (MNI-815) (DRUG).
Who is sponsoring clinical trial NCT02531360?
This trial is sponsored by Molecular NeuroImaging, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02531360's enrollment target sits among peer trials
7 1825th of 2000 higher than 156 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia